An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Hims & Hers Health will have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Drugs like Ozempic® and Mounjaro® have become blockbuster drugs as of late, making headlines not only for their powerful weight loss effects ... as the only three FDA-approved treatments for the ...